Thomas Joseph Dee
Corporate Officer/Principal at Abbott Laboratories Trading (Shanghai) Co. Ltd.
Profile
Thomas Joseph Dee is currently a Principal at Abbott Laboratories Trading (Shanghai) Co. Ltd.
He previously worked as a Non-Executive Director at Abbott India Ltd.
from 2007 to 2013 and as Vice President-International Finance Operations at Abbott Laboratories from 1990 to 2013.
He also served as Chief Financial Officer & Senior Vice President at Novartis Gene Therapies, Inc. from 2015 to 2017.
Dee received his undergraduate degree from Northern Illinois University and his MBA from Kellogg School of Management.
Thomas Joseph Dee active positions
| Companies | Position | Start |
|---|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
 Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Corporate Officer/Principal | 21/09/2011 |
Former positions of Thomas Joseph Dee
| Companies | Position | End |
|---|---|---|
| AVEXIS INC | Director of Finance/CFO | 18/10/2017 |
| ABBOTT INDIA LIMITED | Director/Board Member | 29/09/2013 |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 31/03/2011 |
Training of Thomas Joseph Dee
| Northern Illinois University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBOTT INDIA LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Abbott Laboratories Trading (Shanghai) Co. Ltd.
Abbott Laboratories Trading (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Trading (Shanghai) Co., Ltd. is a subsidiary of Abbott Laboratories SA. It primarily offers medicines. The company is headquartered in Shanghai, China. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Stock Market
- Insiders
- Thomas Joseph Dee
